Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
269.89
USD
0.76%
Market Cap:
$7.3B
Relative Value
The Relative Value of one
BIO
stock under the Base Case scenario is
337.98
USD.
Compared to the current market price of 269.89 USD,
Bio Rad Laboratories Inc
is
Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIO
Relative Value
Base Case
337.98
USD
Undervaluation 20%
Multiples Across Competitors
BIO Competitors Multiples
Bio Rad Laboratories Inc Competitors
Bio Rad Laboratories Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bio Rad Laboratories Inc
NYSE:BIO
|
7.3B USD | 2.8 | 9.5 | 26 | 26 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
990.7B USD | 346.9 | 4 107.3 | 1 176.9 | 2 266.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
182.5B USD | 4.1 | 27 | 19 | 25.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.9B USD | 5.5 | 37.1 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.6B CHF | 5.2 | 35.5 | 26.5 | 26.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.7B CNY | 6 | 17.7 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.6B USD | 4.5 | 24.7 | 19.4 | 23.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.2B USD | 9.1 | 44.9 | 29 | 36.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.1B USD | 1.8 | 21 | 11.8 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25B USD | 6 | 27.9 | 20.8 | 23.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
